A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)

Clinical trial NCT00071812 · COMPLETED

Trial details

NCT number: NCT00071812
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2003-12-01
Primary completion: 2005-01-01
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.